
Abraham Cinta is the CEO of ARC Group, a global advisory firm specialising in reverse takeovers, public listings, and capital markets strategy. ARC Group has advised XRP Healthcare on its TSXV listing structure and public-market positioning.

Charles Chong is a Financial Advisor at ARC Group with experience in public-market readiness, capital structuring, and transaction advisory. He has advised XRP Healthcare throughout the TSXV listing process with a focus on financial structure and disclosure.
Disclaimer: Advisory roles relate solely to capital markets strategy and the TSXV listing process. ARC Group, Abraham Cinta, and Charles Chong are not officers, directors, shareholders, or employees of XRP Healthcare and do not provide funding commitments or operational control.
Last updated: April 2026
Retail network access is facilitated through agreements with United Networks of America (UNA). Display of pharmacy brand marks does not imply ownership, endorsement, or direct partnership with XRP Healthcare M&A Holding Inc.
Technology partnerships reflect collaborative or project-based cooperation. Display does not imply equity ownership or endorsement unless expressly stated.
Pharmaceutical and supply relationships reflect existing commercial arrangements within acquired operating entities. Display does not imply exclusivity or endorsement beyond standard commercial supply agreements.
Advisors provide professional services to XRP Healthcare M&A Holding Inc. No partnership or ownership interest is implied unless publicly disclosed.
All third-party trademarks remain the property of their respective owners. Display does not imply endorsement, ownership, or partnership unless expressly stated.